CEA anticorps (full length) (CF®488A)

N° du produit ABIN7877823

L’anticorps anti-CEA Monoclonal Souris est utilisé pour la détection de CEA dans des échantillons de Humain. Il a été validé pour IHC (p).

Aperçu rapide pour CEA anticorps (full length) (CF®488A) (ABIN7877823)

Antigène: CEA (Carcinoembryonic Antigen Gene Family (CEA))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CEA est conjugé à/à la CF®488A

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: C66-1009

Détail du produit anti-CEA anticorps (CF®488A)

Épitope: full length

Fonction: CEA Antibody / Carcinoembryonic Antigen

Purification: Protein G affinity chromatography

Immunogène: Human full-length recombinant CEA protein was used as the immunogen for this antibody.

Isotype: IgG2a, kappa

Information d'application

Indications d'application: Optimal dilution of the CEA antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: 500 µL at 0.1 mg/mL with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: Store the CEA antibody at 2-8oC, protected from light.

Détails sur CEA

Antigène: CEA (Carcinoembryonic Antigen Gene Family (CEA))

Autre désignation: CEA

Sujet: This antibody recognizes proteins of 80-200 kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70 % are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix.

UniProt: P06731